RegisterLogin

Pelitinib

CAT: 0804-HY-32718-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-32718-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Pelitinib (EKB-569; WAY-EKB 569) is an irreversible inhibitor of EGFR with an IC50 of 38.5 nM; also slightly inhibits Src, MEK/ERK and ErbB2 with IC50s of 282, 800, and 1255 nM, respectively.
CAS Number
[257933-82-7]
Product Name Alternative
EKB-569; WAY-EKB 569
UNSPSC
12352005
Hazard Statement
H301
Target
EGFR; Src
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Pelitinib.html
Purity
99.13
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
N#CC1=C(C2=CC(NC(/C=C/CN(C)C)=O)=C(OCC)C=C2N=C1)NC3=CC(Cl)=C(C=C3)F
Molecular Formula
C24H23ClFN5O2
Molecular Weight
467.92
Precautions
H301
References & Citations
[1]Torrance CJ, et al. Combinatorial chemoprevention of intestinal neoplasia. Nat Med. 2000 Sep;6 (9) :1024-8.|[2]Nunes M, et al. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes. Mol Cancer Ther. 2004 Jan;3 (1) :21-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
EGFR/ErbB1/HER1

Related Products

CatalogName

Alternative Products

CatalogName
019173Pelitinib
MBS6070546-01Pelitinib-d6
A10706-100Pelitinib 100mg
A10706-10Pelitinib 10mg
A10706-5Pelitinib 5mg
A10706-25Pelitinib 25mg
MBS8506549-01Pelitinib (EKB-569)

Popular Products